Nizatidine/AE - Search Results

Year	Number of Results
1991	4
1992	2
1993	3
1994	2
1995	2
1996	2
1997	3
1998	2
2000	2
2002	3
2004	2
2005	2
2006	1
2012	1
2019	1
2020	1
2021	1
2024	1
2026	0

1

Efficacy and safety of rebamipide/nizatidine in patients with erosive gastritis: A randomized, multicenter, phase 4 study.

Kang D, Choi MG, Shim KN, Jung HK, Nam SJ, Park JH, Kim SG, Kim NH, Hong SJ, Jeon TJ, Chung JI, Lee HL, Lee JY, Kim TO, Lee CM, Kim SM, Kim JH, Kim JE, Moon JS, Kim HD, Lee WS, Park HJ. Kang D, et al. World J Gastroenterol. 2024 Dec 28;30(48):5152-5161. doi: 10.3748/wjg.v30.i48.5152. World J Gastroenterol. 2024. PMID: 39735267 Free PMC article. Clinical Trial.

2

Nizatidine anaphylaxis.

Mira-Perceval JL, Ortiz JL, Sarrió F, Miralles JC, Hernández J, Negro-Alvarez JM, López-Sánchez JD, García-Sellés FJ, Pagán JA. Mira-Perceval JL, et al. J Allergy Clin Immunol. 1996 Mar;97(3):855-6. doi: 10.1016/s0091-6749(96)80165-5. J Allergy Clin Immunol. 1996. PMID: 8613644 No abstract available.

3

Nizatidine and acid-pepsin related gastrointestinal disease.

Piper DW, Stiel D. Piper DW, et al. J Gastroenterol Hepatol. 1995 Mar-Apr;10(2):205-7. doi: 10.1111/j.1440-1746.1995.tb01079.x. J Gastroenterol Hepatol. 1995. PMID: 7787168 No abstract available.

4

[Nizatidine: a meta-analytical study].

di Ciommo V, Ferrario F. di Ciommo V, et al. Clin Ter. 1993 Sep;143(3):201-7. Clin Ter. 1993. PMID: 8222550 Italian.

5

[Safety of proton pump inhibitors].

Esplugues JV, Martí-Cabrera M, Ponce J. Esplugues JV, et al. Med Clin (Barc). 2006 Nov 25;127(20):790-5. doi: 10.1157/13095825. Med Clin (Barc). 2006. PMID: 17198667 Review. Spanish.

6

Nizatidine prevents peptic ulceration in high-risk patients taking nonsteroidal anti-inflammatory drugs.

Levine LR, Cloud ML, Enas NH. Levine LR, et al. Arch Intern Med. 1993 Nov 8;153(21):2449-54. Arch Intern Med. 1993. PMID: 8215749 Clinical Trial.

7

Nizatidine for the treatment of pediatric gastroesophageal reflux symptoms: an open-label, multiple-dose, randomized, multicenter clinical trial in 210 children.

Orenstein SR, Gremse DA, Pantaleon CD, Kling DF, Rotenberg KS. Orenstein SR, et al. Clin Ther. 2005 Apr;27(4):472-83. doi: 10.1016/j.clinthera.2005.04.008. Clin Ther. 2005. PMID: 15922820 Clinical Trial.

8

Nizatidine versus placebo in active benign gastric ulcer disease: an eight-week, multicenter, randomized, double-blind comparison. The Nizatidine Benign Gastric Ulcer Disease Study Group.

Cloud ML, Enas N, Offen WW. Cloud ML, et al. Clin Pharmacol Ther. 1992 Sep;52(3):307-13. doi: 10.1038/clpt.1992.146. Clin Pharmacol Ther. 1992. PMID: 1526089 Clinical Trial.

9

Estimation of nizatidine gastric nitrosatability and product toxicity via an integrated approach combining HILIC, in silico toxicology, and molecular docking.

El-Shaheny R, Radwan M, Yamada K, El-Maghrabey M. El-Shaheny R, et al. J Food Drug Anal. 2019 Oct;27(4):915-925. doi: 10.1016/j.jfda.2019.08.001. Epub 2019 Aug 22. J Food Drug Anal. 2019. PMID: 31590763 Free PMC article.

10

Nizatidine versus placebo in gastro-oesophageal reflux disease: a 12-week, multicentre, randomised, double-blind study.

Cloud ML, Offen WW, Robinson M. Cloud ML, et al. Br J Clin Pract Suppl. 1994 Nov;76:3-10. Br J Clin Pract Suppl. 1994. PMID: 7794701 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Results by year